Cyclobutane pyrimidine dimers (CPDs) constitute the most frequent UV-induced DNA photoproduct. However, it has remained unclear how human and other mammalian cells mitigate the mutagenic and carcinogenic potential of CPDs emanating from their replicative bypass. Here, we examine in human cells the roles of translesion synthesis (TLS) DNA polymerases (Pols) in the replicative bypass of a cis-syn TT dimer carried on the leading or the lagging strand DNA template in a plasmid system we have designed, and we determine in mouse cells the frequencies and mutational spectra generated from TLS occurring specifically opposite CPDs formed at TT, TC, and CC dipyrimidine sites. From these studies we draw the following conclusions: (i) TLS makes a very prominent contribution to CPD bypass on both the DNA strands during replication; (ii) Pols , , and provide alternate pathways for TLS opposite CPDs wherein Pols and promote mutagenic TLS opposite CPDs; and (iii) the absence of mutagenic TLS events opposite a cis-syn TT dimer in human cells and opposite CPDs formed at TT, TC, and CC sites in mouse cells that we observe upon the simultaneous knockdown of Pols and implicates a highly error-free role of Pol in TLS opposite CPDs in mammalian cells. Such a remarkably high in vivo fidelity of Pol could not have been anticipated in view of its low intrinsic fidelity. These observations have important bearing on how mammalian cells have adapted to avoid the mutagenic and carcinogenic consequences of exposure to sunlight.
Cyclobutane pyrimidine dimers (CPDs) constitute the most frequent UV-induced DNA photoproduct. However, it has remained unclear how human and other mammalian cells mitigate the mutagenic and carcinogenic potential of CPDs emanating from their replicative bypass. Here, we examine in human cells the roles of translesion synthesis (TLS) DNA polymerases (Pols) in the replicative bypass of a cis-syn TT dimer carried on the leading or the lagging strand DNA template in a plasmid system we have designed, and we determine in mouse cells the frequencies and mutational spectra generated from TLS occurring specifically opposite CPDs formed at TT, TC, and CC dipyrimidine sites. From these studies we draw the following conclusions: (i) TLS makes a very prominent contribution to CPD bypass on both the DNA strands during replication; (ii) Pols , , and provide alternate pathways for TLS opposite CPDs wherein Pols and promote mutagenic TLS opposite CPDs; and (iii) the absence of mutagenic TLS events opposite a cis-syn TT dimer in human cells and opposite CPDs formed at TT, TC, and CC sites in mouse cells that we observe upon the simultaneous knockdown of Pols and implicates a highly error-free role of Pol in TLS opposite CPDs in mammalian cells. Such a remarkably high in vivo fidelity of Pol could not have been anticipated in view of its low intrinsic fidelity. These observations have important bearing on how mammalian cells have adapted to avoid the mutagenic and carcinogenic consequences of exposure to sunlight.
DNA damage and repair ͉ translesion synthesis ͉ UV damage U V light induces the formation of two major photoproducts, cis-syn cyclobutane pyrimidine dimers (CPDs) and (6-4) pyrimidine-pyrimidone photoproducts [(6-4) PPs]. Of the two lesions, PPs are removed rapidly and efficiently by nucleotide excision repair (NER), whereas the removal of CPDs by NER occurs at a much slower rate (1); hence, CPDs constitute a much more important premutagenic lesion than (6-4) PPs, and it has been estimated that CPDs account for Ϸ80% of UV-induced mutations in mammalian cells (2) . Because of their relatively high abundance, slow repair, and the fact that CPDs account for a large majority of UV-induced mutations (3, 4) , in this study we determine the roles that human and mouse translesion synthesis (TLS) Pols , , , and play in TLS opposite CPDs and the relative contributions they make to their error-free vs. mutagenic bypass.
For TLS studies in human cells, we have designed a duplex plasmid system in which bidirectional replication ensues from a replication origin and proceeds through a site-specific cis-syn TT dimer carried on the leading or the lagging DNA strand template. Studies with this plasmid system in human cells have allowed us to make several unanticipated observations, some of which we note here: (i) opposite a cis-syn TT dimer, TLS makes an important contribution to lesion bypass and is predominantly error-free; (ii) different TLS Pols contribute similarly to lesion bypass on the leading and lagging DNA strands; (iii) Pols and provide alternate means for TLS opposite the TT dimer, including for the mutagenic component of TLS; and (iv) Pol performs highly error-free TLS opposite TT dimer.
In addition to the formation of cyclobutane dimers at TT sites, UV induces the formation of dimers at 5Ј-TC-3Ј and 5Ј-CC-3Ј dipyrimidine sites, and both in yeast and humans, UV-induced mutations occur predominantly by a C-to-T transition at the 3Ј base (5) (6) (7) (8) . To obtain a more comprehensive understanding of the error-free vs. mutagenic roles of TLS Pols in promoting replication through CPDs formed at various dipyrimidine sequences, we have analyzed UV mutagenesis in the cII transgene carried in a mouse cell line that additionally harbors a (6-4) PP photolyase gene so that (6-4) photoproducts can be selectively removed. From these mutational analyses we draw two conclusions: (i) whereas Pols and promote mutagenic TLS, Pol carries out error-free TLS at an unexpectedly high rate opposite CPDs formed at various dipyrimidine sequences; (ii) Pols and display a surprisingly high degree of specificity for the dipyrimidine sites upon which they respectively act. We discuss the implications of these results and various other observations for TLS opposite CPDs in human and mouse cells.
Results

Construction of Heteroduplex Target Vectors Containing a Site-
Specific cis-syn TT Dimer. We have constructed duplex plasmid vectors containing a site-specific cis-syn TT dimer ( Fig. S1 A Left), where bidirectional replication initiates from an SV40 replication origin. In vivo studies with SV40 in mammalian cells and in vitro studies with reconstituted mammalian cell-free systems with circular plasmids that harbor an SV40 origin of replication sequence and require the SV40 T antigen, have shown that replication ensues from the SV40 origin and proceeds bidirectionally terminating approximately half way around the circular molecule from the initiation point (9) (10) (11) (12) .
The system we have designed is based on pBluescript (ϩ/Ϫ) vector, where the sense (ϩ) and the antisense (Ϫ) single stranded circular DNAs can be separately purified. The bacterial lacZЈ gene in pBluescript is used for selection in the TLS assays. The multiple cloning site within the LacZЈ gene in pBluescript vector was replaced with a specific target sequence, one strand of that contains an SpeI site and the other strand carries a cis-syn TT dimer (Fig. S1B  Left) . Using such a plasmid system, we can obtain information not only on different aspects of TLS during replication in human cells, but can also distinguish any differences in TLS on the leading vs. the lagging DNA strand. For this reason, we constructed two vectors, one in which the lesion is located on the leading strand template (pBS vector), and the other where the lesion is on the lagging strand template (pSB vector) (Fig. S1B Left) . The basic strategy for the construction of heteroduplex plasmid containing a site-specific cis-syn TT dimer on the leading or the lagging strand template is shown in Fig. S1B and described in the SI Text.
Contributions of Pols , , , and to TLS Opposite a cis-syn TT Dimer.
To determine the roles of different TLS Pols in promoting replication through a cis-syn TT dimer in human cells, we used duplex siRNAs to inhibit their expression (13) . That the siRNA knockdown was highly efficient was verified by RT-PCR (Fig. S2) and by Western blotting analysis (Fig. S3) . To avoid the possibility of TT dimer removal by NER that would occur in normal human cells, we used XPA human fibroblast (HF) cells so that we could obtain a good estimate of the frequency with which TLS operates opposite this lesion in human cells. XPA(HF) cells were first transfected with siRNA for 48 h to inhibit the expression of the TLS Pol and then the site-specific lesion-containing plasmid and the siRNA were cotransfected into these pre-siRNA treated cells (see step IV in Fig.  S1B ). Cells were then incubated for Ϸ30 h to allow for the replication of plasmid, the plasmid was isolated (step V in Fig. S1B ), and the frequencies of TLS (steps VI and VII in Fig. S1B ), determined from the number of blue colonies relative to the total Kan ϩ colonies, and the identity of the nucleotide, incorporated during TLS, were analyzed (Fig. S1C) . As expected, with undamaged plasmid, the frequency of blue colonies among total Kan ϩ colonies that result from the replication of undamaged TTcontaining DNA strand was not altered in different experiments and with siRNA knockdowns of different TLS Pols regardless of whether the undamaged TT was on the leading or the lagging strand template. Hence, any reduction in the frequency of blue colonies among the total Kan ϩ colonies with damaged plasmid upon depletion of a TLS Pol represents the contribution of that Pol to TLS opposite the lesion.
In XPA cells treated with control (NC) siRNA (Table 1) , TLS contributes to lesion bypass on the leading strand to a higher extent (Ϸ41%) than on the lagging strand (Ϸ27%), and these differences for the two DNA strands are highly significant (P Ͻ 0.0001). Template switching using copy choice type of DNA synthesis or recombinational repair presumably accounts for the remainder of lesion bypass. For both the DNA strands in XPA cells, Pol knockdown conferred Ϸ50% reduction in the frequency of TLS compared with that in control cells treated with NC siRNA. Upon Pol knockdown, we observed no reduction in TLS frequencies opposite the TT dimer on either DNA strand, and even the simultaneous knockdown of Pols and caused no further reduction in TLS frequencies over that seen upon the knockdown of Pol alone (Table 1) . Interestingly, Pol knockdown resulted in Ϸ30% reduction in the frequency of TLS opposite the TT dimer carried on either of the DNA strands, and the knockdown of either Pol subunit-Rev3 or Rev7-conferred a reduction in TLS frequencies similar to that from Pol knockdown ( Table 1 ). The simultaneous knockdown of Pol and Pol led to a further reduction in TLS frequencies over that seen upon the knockdown of either Pol alone. TLS on both the DNA strands was reduced by Ϸ50% upon Pol plus Pol knockdown compared with the 20-30% reduction seen upon the knockdown of either Pol alone (Table 1) . To determine whether Pols and function independently of Pol, we examined TLS frequencies opposite the TT dimer upon the simultaneous knockdowns of Pol with Pol and of Pol with Pol. An approximate 30% further reduction in the frequencies of TLS occurs in cells upon the simultaneous knockdown of Pol with Pol and of Pol with Rev3 compared with the results seen for Pol knockdown alone (Table 1) . We verified that for both the DNA strands, the reductions observed in TLS frequencies upon Pol knockdown or upon the simultaneous knockdown of Pols and were in fact statistically highly significant (P Ͻ Ͻ 0.0001). From these observations we infer that Pols , , and provide alternative means of promoting replication through a cis-syn TT dimer.
To further ascertain the inference that Pols , , and provide three alternate means of TLS opposite a cis-syn TT dimer and that Pol makes no contribution to TLS opposite this lesion, we examined the effects of knockdowns of these Pols in an XPV cell line. As shown in Table 2 , we found that whereas the knockdown of Pol has no effect on TLS for either DNA strand, the knockdown of either Pol or Pol conferred a decrease in TLS frequencies, and a further decrease in TLS occurred upon their simultaneous knockdown. For both the DNA strands, the reduction in TLS frequencies that we observe in XPV cells upon the simultaneous knockdown of Pols and , compared with that for control (NC) siRNA-treated cells, is very highly significant (P Ͻ Ͻ 0.0001), and it is very likely the much reduced level of TLS that still remains after the knockdowns of both Pols and in XPV cells derives from the residual levels of these Pols that persist in such cells.
Mutational Analyses of Products Resulting from TLS Through a cis-syn
TT Dimer. Sequence analyses of TLS products resulting from TT dimer bypass indicate that on both DNA strands, replication through this UV lesion occurs predominantly in an error-free manner, because in XPA cells transfected with control (NC) siRNA only Ϸ2% of the TLS products carry mutations resulting from a G or a T insertion opposite the 3ЈT or the 5ЈT (Tables S1 and S2) . Compared with control XPA cells, the mutation frequency rises *Because the lesion-containing DNA strand in the duplex plasmid is kan ϩ (the other strand being kan Ϫ ), and because TLS through the lesion would produce a blue colony, the TLS frequencies are determined from the number of blue colonies relative to the total colonies on LB ϩ kan plates containing IPTG and X-gal.
approximately 2-fold for TLS on both DNA strands upon Pol knockdown, but the mutational pattern remains approximately the same as in control XPA cells, except for the incorporation of a C opposite the 3ЈT that is observed only in cells deficient for Pol (Tables S1 and S2 ). In XPA cells with Pol knockdown, we observed no significant change in mutation frequencies or in mutational pattern for TLS on either DNA strand (Tables S1 and S2 ). We also determined whether simultaneous knockdown of Pols and causes any change in mutation frequencies or in mutational pattern from that observed upon Pol knockdown alone. As shown in Table S1 , however, we found no additional effect of Pol knockdown in cells with diminished Pol expression. To further verify the lack of involvement of Pol in TT dimer bypass, we sequenced the TLS products from XPV cells transfected with Pol siRNA. However, the mutational analyses of approximately 300 TLS products showed no differences in either the frequency or the pattern of mutations generated upon Pol knockdown in XPV cells from that in XPV cells transfected with control siRNA. Thus, all our observations indicate that Pol plays no significant role in promoting replication through a cis-syn TT dimer.
We find that the knockdown of Pol or the Rev3 or Rev7 subunits of Pol confers Ϸ50-70% reduction in mutation frequency for TLS opposite the TT dimer on both the DNA strands (Tables  S1 and S2 ). The simultaneous knockdown of Pol with Rev3 or with Rev7 resulted in a further decline in the incidence of mutagenic TLS; and most interestingly, among almost 2,000 TLS products analyzed for both the DNA strands, we could find no evidence of a mutational change (Tables S1 and S2) . A comparison of pooled data for both the DNA strands in XPA cells treated with control siRNA vs. in XPA cells, where both Pols and have been knocked down, shows that the observed differences between them are very highly significant (P Ͻ Ͻ 0.0001).
In summary, our findings that Pols and provide alternate pathways for TLS opposite a TT dimer and that these two Pols are responsible for all of the mutagenic TLS through the TT dimer have allowed us to deduce the important conclusion that Pol functions in TLS opposite TT dimer in humans with a very high fidelity, and as we discuss in the next section, from studies in mouse cells we are able to verify and extend this conclusion to CPDs not only at TT dipyrimidine sites, but at TC and CC sites as well.
Contributions of TLS Polymerases to UV Mutagenesis Resulting from
Bypass of CPDs at TT, TC, and CC Sites in Mouse Cells. Although our analyses with a site-specific cis-syn TT dimer carried on the leading or the lagging strand DNA template are highly informative for the relative contributions of TLS to lesion bypass and for the roles different Pols play in TLS opposite this lesion in human cells, the plasmid system does not allow us to examine TLS opposite CPDs at TC and CC sites. Because UV-induced mutations occur predominantly by a C-to-T transition at the 3ЈC of CPDs, it becomes important to examine TLS through such sites as well. Therefore, to obtain a more comprehensive view of the roles of various Pols in TLS opposite CPDs formed at various dipyrimidine sites, we used the big blue mouse embryonic fibroblast (BBMEF) cell line in which 40 copies of LIZ shuttle vector have been integrated into the genome. This vector carries two reporter genes-lacI and cII-for mutational analyses (2) . We chose to examine UV mutations in the cII gene because it is only 294-bp long and hence more convenient for sequence analyses (14) . This system has been used extensively for mutational analyses in mammalian cells and it shows similar mutational responses to different DNA damaging agents as those observed with endogenous chromosomal genes (2, 8, 15) . To measure the frequencies and types of mutations generated from TLS opposite CPDs, we selectively removed the (6-4) photoproducts (PPs) from the genome by expressing a (6-4) photolyase gene in the mouse embryonic fibroblast cell line, as described in ref. 2 . As has been reported (2), the experimental protocol we have used allows for the complete removal of (6-4) PPs and we have independently verified this fact.
To examine the role of various Pols in promoting error-free vs. error-prone TLS opposite CPDs formed at TT, TC, and CC sites, we used siRNA knockdown in big blue mouse embryonic fibroblasts expressing the (6-4) PP photolyase and determined the frequencies of UV-induced mutations in the cII gene. The highly efficient siRNA knockdown of mouse Pols , , , and Rev3 was verified by RT-PCR (Fig. S4) , and this knockdown efficiency was maintained for at least 4 days. The frequency of mutations in the cII gene in unirradiated cells treated with control (NC) siRNA and with or without exposure to photoreactivating light was Ϸ16 ϫ 10 Ϫ5 (Table 3) , and in non-UV-irradiated cells, the siRNA knockdown of any of the Pols , , , or Rev3 singly or in combinations had no effect on this mutation frequency. As shown in Table 3 , when mouse cells expressing the (6-4) PP photolyase were UV irradiated (5 J/m 2 ) but not exposed to photoreactivating light, the cII mutation frequency increased Ϸ4-fold to Ϸ57.0 ϫ 10 Ϫ5 . To estimate the contribution of CPDs to this mutation frequency, the UV-irradiated cells were exposed to photoreactivating light for 3 h to remove (6-4) PPs by the action of the (6-4) PP photolyase. Photoreactivation reduced the mutation frequency to Ϸ45 ϫ 10 Ϫ5 , indicating that under these experimental conditions almost 80% of UV mutations result from TLS opposite CPDs (Table 3 ). In the cell line that was transfected with the vector only control instead of the plasmid harboring the (6-4) PP photolyase gene, the mutation frequency remained the same (Ϸ57 ϫ 10 Ϫ5 ) with or without photoreactivating treatment.
Next, we examined the effects of knockdowns of Pols , , , or Rev3, and of the simultaneous knockdown of Pol and Rev3 on UV-induced cII mutation frequencies, resulting from TLS opposite CPDs. Whereas compared with the mutation frequency of Ϸ45 ϫ 10 Ϫ5 in NC siRNA-treated cells, the knockdown of Pol conferred an Ͼ2-fold increase in mutation frequency to Ϸ105 ϫ 10 Ϫ5 , the knockdown of Pol had no effect on mutation frequencies opposite CPDs ( Table 3 ). The knockdown of either Pol or Rev3, the catalytic subunit of Pol, reduced mutation frequency from Ϸ45 ϫ 10 Ϫ5 by Ͼ30% to Ϸ30 ϫ 10 Ϫ5 . Interestingly and most importantly, the simultaneous knockdown of Pol and Rev3 led to a drastic decline in the mutation frequency to Ϸ17 ϫ 10 Ϫ5 , which is very similar to mutation frequencies (Ϸ16 ϫ 10 Ϫ5 ) observed in unirradiated cells (Table 3) . We draw two conclusions from these observations: (i) Pols and contribute almost equally to TLS opposite CPDs formed at various dipyrimidine sites, and they are responsible for almost all of the mutagenic component of TLS opposite CPDs. (ii) Our observation that the simultaneous inactivation of Pols and reduces mutation frequency to a level that is very similar to that in undamaged cells leads us to conclude that in vivo, Pol carries out TLS opposite CPDs formed at TT, TC, or CC dipyrimidine sites in a highly error-free manner.
Next, we determined the types of mutations that were formed in UV-irradiated BBMEF cells expressing (6-4) PP photolyase and exposed to photoreactivating light. As shown in Table S3 , in cells treated with control (NC) siRNA Ϸ65% of UV-induced mutations were C-to-T transitions, and the preponderance of C-to-T transitions remained approximately the same in cells treated with siRNAs for Pols , , or Rev3; by contrast, the simultaneous knockdown of Pols and Rev3 led to a reduction in the frequency of C-to-T transitions, similar to that in unirradiated cells.
In Fig. 1 , we compare the pattern of mutations resulting from TLS opposite CPDs in the cII gene after the knockdown of different Pols. In control cells treated with NC siRNA, the preponderance of UV-induced mutations are seen to occur at particular dipyrimidine sequences that we have labeled with nos. 1-11 ( Fig. 1 A) . Although the frequency of UV-induced mutations is elevated upon Pol knockdown (Table 3) , the pattern of mutational hotspots upon Pol knockdown resembles that in control cells (Fig. 1 A) . In striking contrast, a remarkably distinct pattern of UV-induced mutations is observed upon Pol vs. Rev3 knockdown, given that a very different set of hotspots remain after the knockdown of Pol (nos. 4, 5, 7, 8) vs. the knockdown of Rev3 (nos. 1, 2, 3, 6); whereas the incidence of mutations at hotspot positions 9-11 is greatly diminished upon the knockdown of either Pol or Rev3 (Fig. 1B) . Remarkably, none of the UV-induced mutational hot spots that occur in cells treated with control siRNA or with Pol siRNA remain when both Pol and Rev3 have been simultaneously knocked down, and the overall distribution and pattern of mutations in these cells becomes very similar to that seen in non-UV-irradiated cells (Fig. 1C) . (30-40%) ; (ii) although TLS occurs less frequently on the lagging strand than on the leading strand, the relative contributions and the mutagenic vs. the error-free roles of different TLS Pols are similar for both DNA strands; (iii) TLS opposite a TT dimer occurs in a predominantly error-free manner: only Ϸ2% of TLS events are mutagenic and all of the mutations involve a base change at the 3ЈT or 5ЈT of the dimer; and (iv) Pols , , and provide three alternate pathways of TLS opposite a TT dimer, with Pol responsible for Ϸ50% of lesion bypass and Pols and contributing about equally and accounting for the remainder of TLS. Although the observations that UVinduced mutation frequencies increase in XPV cells had indicated an error-free role of Pol in replicating through CPDs, from such observations one could not have known how frequently Pol generates errors during TLS in human cells. That is because the increase in mutation frequencies in XPV cells is indicative only of Pol being more error-free than the Pol(s) that replicate through the lesion in the absence of Pol, but that yields no information on the extent by which Pol is error-free in human cells. In this study, the identification of Pols and as the alternate mutagenic TLS pols opposite a TT dimer has enabled us to examine this issue in depth, and our observation that we could find no mutagenic events among the almost 2,000 TLS products examined from human cells, where both Pols and have been depleted, suggested that the error rate of TLS by Pol opposite a TT dimer could be approximately 1 ϫ 10 Ϫ3 . However, as we discuss this point further in the next section, we estimate that Pol's error rate opposite CPDs is likely to be considerably lower than that.
Pol Carries Out Highly Error-Free TLS Opposite CPDs at TC, CC, and
TT Dipyrimidine Sites. From our plasmid studies in human cells, we could infer that Pol carries out TLS opposite a cis-syn TT dimer with an error frequency of approximately 1 ϫ 10 Ϫ3 . Because this fidelity estimate was restricted to a TT dimer and because the need for sequencing TLS products greatly limited the number of mutational events that could be analyzed, we resorted to examining the frequency of UV-induced mutations that would result from TLS opposite CPDs formed at TC, CC, and TT dipyrimidine sites in the cII transgene in mouse cells. Interestingly and importantly, with this system we found that whereas the knockdown of either Pol or Pol led to a reduction in the frequency of UV-induced mutations, the simultaneous knockdown of both Pols and lowered the frequency of UV-induced mutations to nearly the same level as that in unirradiated cells. Furthermore, in cells knocked down for both Pols and , the increase in the frequency of C-to-T transitions that is so characteristic of mutagenic TLS of CPDs at TC and CC sites was reduced to almost the same level as in unirradiated control cells, and the mutational spectra of UV-induced mutations opposite CPDs in these cells resembled closely the pattern of mutations that occur spontaneously. We conclude from these various observations that Pol from humans and mice carries out TLS opposite CPDs formed at TC, CC, and TT sites with an error frequency that does not confer a significant increase in spontaneous mutation frequency. Such a high fidelity of mammalian Pol opposite CPDs could not have been anticipated because steady-state kinetic studies have indicated that both on undamaged and cis-syn TT dimercontaining DNAs, human Pol misincorporates nucleotides with a frequency of Ϸ10 Ϫ2 , and in an in vitro gap-filling assay, human Pol introduced 1 error in Ϸ30 nucleotides incorporated (16, 17) . Thus, by contrast to its very low intrinsic fidelity indicated from biochemical studies, in mouse and human cells Pol carries out TLS opposite CPDs with a substantially higher fidelity. We presume that Pol achieves its high fidelity opposite CPDs in mammalian cells via its association with protein factors that remain to be identified.
Pol Has No Role in TLS Opposite
CPDs. We find that the Pol knockdown has no effect on TLS opposite the cis-syn TT dimer in plasmid assays in human cells or on the frequency of mutations resulting from TLS through CPDs formed at various dipyrimidine sites in the cII gene in mouse cells. The lack of any involvement of Pol in CPD bypass is in keeping with the biochemical studies indicating that this Pol is strongly inhibited in synthesizing DNA opposite a cis-syn TT dimer (18, 19) . Also, structural studies have indicated that the two covalently linked pyrimidine residues of a CPD could not be accommodated in the Pol active site (20) (21) (22) . And moreover, even opposite undamaged T and C residues, Pol inserts nucleotides with a very low efficiency and fidelity (18, 19) . Hence, from all of these different observations, we can infer that Pol plays no significant role in TLS opposite CPDs.
TLS Through CPDs in Mammalian Cells. From considerations of our analyses of TLS through a cis-syn TT dimer in plasmid assays in human cells and of cII mutational assays in mouse cells, we propose a scheme for TLS through the CPDs in human and other mammalian cells (Fig. S5) . In this scheme, Pol carries out predominantly error-free TLS through the CPDs, and Pols and provide alternate pathways of TLS in which mutations could arise at a frequency of Ϸ5 ϫ 10 Ϫ2 . Because Pols and would act at the extension step, there must be an as yet unidentified DNA polymerase that is able to insert nucleotides opposite CPDs, and we presume that even though this polymerase inserts a wrong nucleotide opposite CPDs, it does so with an error frequency of Ϸ5 ϫ 10 Ϫ2 .
The roles of Pols and in extending from the nucleotide inserted opposite the 3Ј residue of a CPD by another Pol have been indicated from biochemical studies (19, 23) ; whereas both these Pols are strongly inhibited from inserting a nucleotide opposite the 3ЈT of the lesion (19, 24, 25) . Furthermore, structural studies with Pol have shown that its active site is very constrained, and it could not accommodate the two Ts of a TT dimer; hence Pol is unable to act at the insertion step. However, there are no structural constraints for Pol performing the extension step (26) .
Although the involvement of Pol in error-free TLS through CPDs has been suggested from the increase in UV mutation frequencies observed in XPV cells (27, 28) , and biochemical evidence and structural studies have indicated a specialized role of Pol in efficient CPD bypass because of its unique ability to accommodate both the pyrimidine residues of a CPD in its active site (16, (29) (30) (31) , the high fidelity of CPD bypass by Pol in mouse and human cells that our studies have revealed could not have been anticipated from any of the previous observations. This conclusion was made possible from our finding that Pols and provide alternate means of mutagenic TLS and that in their absence, the TLS that is carried out by Pol is virtually error-free.
Materials and Methods
For TLS studies in human cells, we constructed a duplex plasmid system that carries an SV40 replication origin and in which a cis-syn TT dimer is present on the leading or the lagging DNA strand; hence, TLS through the DNA lesion can be separately analyzed for the two strands during replication. We used siRNA treatment to achieve high efficiency depletion of various TLS Pols in human cells and determined the effects of their depletion on the frequency of TLS and analyzed whether TLS occurred in an error-free or mutagenic manner. To examine the roles of various Pols in mutagenic vs. error-free TLS opposite CPDs formed at TT, TC, and CC dipyrimidine sites, frequencies of UV-induced mutations were examined in the cII gene carried in big blue mouse embryonic fibroblast (BBMEF) cells in which (6-4) photoproducts were specifically removed from the genome by expressing a (6-4) photolyase gene and where the TLS Pols had been depleted by siRNA treatment.
The detailed methods for plasmid constructions, TLS assays, and mutational analyses of TLS opposite a cis-syn TT dimer in human cells are given in SI Text and shown in Fig. S1 . The methods for siRNA knockdown of TLS Pols and for verifying their knockdown efficiency in human cells are also described in SI Text, and the related information is provided in Tables S4 and S5 Tables S6 and S7 and Fig. S4 .
